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ABSTRACT
Objective: Obstructive sleep apnea (OSA) is a condition characterized by complete/partial obstruction of the upper airway that disrupts normal sleep 
pattern. It has become highly prevalent and negatively affects the quality of life. Reports show ≥4% of men and ≥2% of women, and mostly, the obese 
individuals are affected by OSA. OSA is independently associated with an increased likelihood of hypertension, cardiovascular disease, and diminished 
quality of life. Hence, it becomes a prime concern for health-care personnel to diagnose it at earliest. A screening tool is necessary to stratify patients 
based on their clinical symptoms, their physical examinations, and their risk factors. Thus, this study was taken up to assess the prevalence of OSA 
using the STOP-Bang questionnaire.
Methods: A total number of 1012 participants were selected using random sampling technique from various community health camps for the study. 
The participants were asked to fill in the STOP-Bang questionnaire. All questionnaire respondents were precisely briefed about this study in a face-to-
face interview. Data obtained from the survey were subjected to statistics, and descriptive analysis was done.
Results: The prevalence of OSA was found to be 13.7% by using the Stop Bang questionnaire. It was found that the prevalence of OSA was highest in 
the age group of 50–59 (21.7%) and least in the age group of 18–29 (12.0%). Gender-wise distribution of OSA based on the scoring was seen to be 
more, among males (14.8%) and females showed a prevalence of 12.9%.
Conclusion: This study concludes that the STOP-Bang method of screening showed a prevalence of 13.7%. However, the prevalence of OSA did not 
show any significant difference in various age groups; it was found that males had a higher prevalence of OSA compared to females.
Keywords: Questionnaire survey, Obstructive sleep apnea, Prevalence, Snoring, Surveys and questionnaires.
INTRODUCTION
Obstructive sleep apnea syndrome (OSAS) is a disorder of breathing 
during sleep characterized by prolonged partial upper airway 
obstruction or intermittent complete obstruction that disrupts 
normal sleep patterns and are often associated with arousals, sleep 
fragmentation, intermittent hypoxia, and hypercapnia including 
excessive daytime sleepiness, growth failure, school failure, behavioral 
problems or cor pulmonale, automobile accidents, or even sudden 
death. OSAS has long been recognized as a major contributor to 
morbidity and mortality in developed countries. The prevalence of 
OSAS based on the Wisconsin cohort study performed in the USA 
involving middle-aged adults 30–60 years of age, is 2% in females and 
4% in males (Young, 1993). According to a survey conducted on a semi-
urban Indian population, it was found that around 6.2% among total 
sample were diagnosed with high-risk OSAS and 33.5% of the obese 
population were at high risk of OSAS [1].
The public health impact of OSAS is now enormous in developing 
countries like India because of increasing urbanization as well as 
lifestyle modification and its potential contribution to the increased 
rates of cardiovascular disease and obesity. In 2006, a population-
based survey from North India had estimated the prevalence of OSAS 
at 3.6% (males and females being 4.9% and 2.1%, respectively). They 
found the prevalence of OSA to be 13.7% [2]. There is not much data 
regarding the prevalence of OSA in the Indian population. Hence, this 
study was designed to study the prevalence of OSA by using the STOP-
Bang questionnaire.
METHODS
The present study was approved by the Institutional Human Ethics 
Committee, Institute of Medical science and SUM Hospital, Bhubaneswar, 
Odisha (DMR/IMS-SH/SOA/10657). A written informed consent was 
obtained from all the participants after giving the information sheet 
and explaining the procedure. Permissions were obtained from the 
hospital authority of Institute of Medical Science and SUM Hospital for 
recruitment of participants for evaluation of OSA (July 2016–July 2017).
Participants
To collect the data, the questionnaires were distributed in various 
camps conducted by the Department of Public health Dentistry. They 
were explained about OSA and its effect on health and were asked 
to participate in the study. Interested participants were explained 
about the questionnaire survey in detail and were asked to fill 
the questionnaire. Finally, the data were collected from 507 male 
participants and 505 female participants who cooperative and were 
willing to be a part of the survey.
The final 1012 participants of the study population who were incused 
in the study were more than 18 years and did not have any history of 
major illness. The patients having any history of myocardial infarction, 
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chronic obstructive pulmonary disease, and upper-airway surgery 
were excluded from the study. The participants were given STOP-Bang 
questionnaire by trained interviewers and were explained regarding it.
Sample size and sampling technique
The formula for the sample size with (1-α)% confidence level and with 
maximum marginal error of estimate of “d” for constructing confidence 
interval of true prevalence using normal approximation has been used. 
The formula is as follows:
( )







Where P is a predetermined value of the prevalence of OSA that is 
ascertained by previous published data. α = the probability of rejecting 
the null hypothesis, when it is true is taken as 0.05, = standard normal 
value of Z is taken as 1.96. p=30%, d=4% point in the absolute term, 
with this input, the minimum sample size n works out to be 505.
Since the aim was to estimate the same among males and females. Our 
minimum sample size was 507 males and 505 females, and the total 
sample size was 1012.
Stop-bang questionnaire
The STOP-Bang questionnaires were developed in response to the need 
for a concise, user-friendly OSA screening tool in pre-operative clinics. 
The STOP-Bang questionnaire includes the four questions used in the 
STOP questionnaire plus four additional demographic queries,20 for 
a total of eight dichotomous (yes/no) questions related to the clinical 
features of sleep apnea (snoring, tiredness, observed apnea, high blood 
pressure, body mass index (BMI), age, neck circumference, and male 
gender). For each question, answering “Yes” scores 1, a “No” response 
scores 0, and the total score ranges from 0 to 8. The components of 
STOP questionnaire were selected based on the factor analysis of 14 
candidate questions designed to reflect snoring, daytime tiredness, 
observed breathing cessation, and high blood pressure. The “bang” 
items were chosen based on univariate analysis of item predictive 
performance [3].
The questionnaire can be completed quickly and easily (usually within 
1–2 min), and overall response rates are typically high (90%–100%). 
The questionnaire has demonstrated a high sensitivity using a cutoff 
score of 3: 84% in detecting any sleep apnea (apnea-hypopnea index 
[AHI] >5 events/h), 93% in detecting moderate-to-severe sleep apnea 
(AHI >15 events/h), and 100% in detecting severe sleep apnea (AHI 
>30 events/h). Corresponding specificities were 56.4%, 43%, and 
37%. If patients score 0–2 on the STOP-Bang questionnaire, they are 
considered to be at low risk of OSA, and the possibility of those patients 
having moderate-to-severe sleep apnea can be confidently ruled out 
(Chung, 2008).
Statistical analysis
Sigma plot 13 (Systat software, USA) software was used to analyze the 
data collected through questionnaires. Descriptive statistics were done 
based on the demographic data. The association of age and gender with 
STOP-Bang questionnaire was done using Chi-square test. Results were 
presented with 95% confidence interval.
RESULTS
A total sample of 1012 participants, who reported to the hospital for a 
routine checkup, were included in the study, of which 507 were male 
and 505 were female. From these samples, 424 were in the age group of 
18–29 years, 166 were in the age group of 30–39 years, 183 were in the 
age group of 40–49 years, 124 were in the age group of 50–59 years, 83 
were in the age group of 60–69 years and 32 were aged above 70 years.
In the present study, it was found that about 13.7% of the participants 
were diagnosed with OSA (Table 1). Out of the total participants who 
were diagnosed with OSA, 30 participants were having moderate, and 
45 participants were having severe OSA (Graph 1). The STOP-Bang 
score was seen to be highest in the age group 50–59 years (21.7%), 
followed by the age group of 40–49 years (15.8%). STOP-Bang score for 
the age group of 18–29 years was 12% and for 30–39 years was 12.6%. 
STOP-Bang score for the age group 70 and above is 12.5% (Table 2). 
This might be due to less number of participants in that age group. The 
Chi-square test did not show any statistically significant result in the 
association of OSA in various age group (p=0.224).
Gender-wise distribution of OSA based on the STOP Bang was seen to 
be highest, among males (14.8%) and females showed 12.9% (Graph 2). 
The Chi-square test did not show any statistically significant result in 
the association of OSA in different genders (p=0.326).
DISCUSSION
OSA has turned out to be a relatively common condition occurring due 
to the obstruction of recurrent upper airway sleep. The development of 
negative intrapharyngeal during inspiration and collapse of the airway 
is prevented by the action of the pharyngeal abductor and dilator 
muscles [4]. Rhythmic activation of these muscles occurs during daytime 
respiration; however, during sleep, the muscles become hypotonic, 
and thus airway stability relies on pharyngeal size and pharyngeal 
tissue compliance, which leads to a reduction in dimension of airway 
Table 1: Prevalence of sleep apnea
Method Sleep apnea n (%)




Table 2: Prevalence of sleep apnea in the different age group






70 or more 4 (12.5)
Total 138 (13.7)
Chi-square, p χ2=3.01, df=1, P=0.224
%: Percentage, n=1012
Graph 1: Prevalence of obstructive sleep apnea in different 
categories according to the STOP-Bang questionnaire. SB: STOP-
Bang score, sample size: Male: 507, Female: 505
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paving the way for OSA. OSA is more prevalent in men (2–3 times) in 
comparison to women, and this has been linked to the pattern of fat 
distribution and difference in sex hormones.
Various chronic effects and hazardous comorbidities have been 
associated with OSA, if left undiagnosed. OSA is characterized by 
markedly elevated sympathetic nerve traffic while awake which may 
aid in chronic elevation of blood pressure. Increased left ventricular 
wall thickening has been observed in patients with OSA [5]. The left 
ventricular hypertrophy is an adverse prognosis of OSA and may also 
lead to impaired myocardial contractility [6]. Studies have suggested 
racial differences contribute to the pathogenesis of OSA, for example, 
when compared to Caucasians; Asians have shorter maxillae and 
mandible, smaller anterior-posterior facial dimensions, and lower BMI. 
This suggests that constriction of the rib cage is of greater importance 
than obesity and soft-tissue factors in the pathogenesis of OSA in 
Asians [7].
OSA, when left untreated, may lead to life-threatening consequences. 
Polysomnography remains ‘‘gold standard’’ for OSA diagnosis; however, 
unfortunately, it is expensive and has less accessibility. Hence, many 
questionnaire methods have been developed to screen OSA, such as – 
American Society of Anesthesiologists, STOP questionnaire (snoring, 
tiredness, observed apnea, and high blood pressure), and STOP-
Bang questionnaire (STOP including BMI, age, neck circumference, 
and gender), were validated on surgical patients; the Wisconsin 
questionnaire which was validated on patients selected from the 
general population, the Berlin questionnaire was validated in different 
target populations, i.e. sleep clinic patients, general population, 
and surgical patients, and Epworth sleepiness scale (ESS) which is a 
standard questionnaire to measure daytime sleepiness [8].
Various studies have been conducted for assessing the prevalence 
in different ethnic and racial groups; however, most of these studies 
were limited to the white population. Hence, the global prevalence of 
OSA cannot be reliably compared. In a study on a group of the Chinese 
population, it was found that there was the prevalence OSA in the 
Chinese population is only 4% similar to the Western studies [9]. 
Another study showed that East Asian men were less obese but had 
a [10] greater severity of OSA. It was also found that the prevalence of 
OSA is more in the Urban Indian population. It was 7.5% higher than 
the rates obtained from other epidemiological studies done across the 
globe [11].
A population-based study from North India estimated that the 
prevalence of OSAS at 3.6% and OSA to be 13.7% [2]. A study from 
South Delhi reported the prevalence of OSA to be 9.3% and OSAS 
to be 2.8% [12]. Another hospital-based study from North India 
estimated the prevalence of OSA and OSAS to be 4.4% and 2.4% in 
males and 2.5% and 1% in females [13]. The prevalence of OSA in 
the Indian population is three-fold higher in men as compared to 
women (Reddy, 2009). According to a study by Singh et al., in North 
Indian population, it was found that 6.2% of the total populations 
were at high risk of OSAS whereas 33.5% of the obese population 
was at high-risk OSAS [1]. In our study, the prevalence of OSA was 
found to be 13.7% according to the STOP-Bang score which may be 
attributed to the higher BMI and presence of central obesity in this 
population (Table 1).
In an earlier study, it was found that the STOP-Bang questionnaire has 
high sensitivity for detecting OSA for moderate and severe OSA (93% 
and 100%, respectively), yet the specificity at the same cutoff of the 
STOP-Bang questionnaire was still low: 47% and 37% for moderate 
and severe OSA, respectively, resulting in fairly high false-positive 
rates [3]. Silva et al. reported that the STOP-Bang questionnaire had 
the highest sensitivity for moderate-to-severe (87.0%) and severe 
sleep-disordered breathing (SDB) (70.4%) in comparison to the ESS 
and the STOP questionnaire. STOP and STOP-Bang questionnaires 
had the advantage of being easily scored. Moreover, they were 
considered the most accurate questionnaires for OSA screening in 
surgical patients [14]. In another study done by El-Sayad, it was seen 
that the sensitivity of the STOP-Bang questionnaire was again higher 
compared to Berlin and STOP Questionnaire. The sensitivity recorded 
for moderate-to-severe SDB and severe SDB was 95.07% and 91.97%, 
respectively [15].
The present study is the first population-based survey of the prevalence 
of OSA done in Odisha. In this study, the prevalence of OSA could be 
clearly related to the increase in age. OSA was more prevalent in the 
older age group of 50–59 years (21.7%). It was similar to a study done 
by Marques et al. which shows the highest prevalence with the mean 
age of 56 years. This clearly indicates that age being a strong risk factor 
for SDB over the middle decades of life (Table 2).
The present study also compared gender difference with respect to 
the prevalence of OSA. The prevalence of OSA was seen to be highest, 
among males (14.2%) and females showed a prevalence rate of 11.7% 
(Graph 2). The male-to-female ratio is estimated between 3:1 and 5:1 in 
the general population and at 8:1–10:1 in some clinical populations [16].
Early clinical observations by Wilhoit and Suratt noted that 
OSA was quite rare in premenopausal women in comparison to 
postmenopausal women, attributing the disease to craniofacial 
abnormalities and severe obesity [17]. Bixler et al. studied about pre 
and postmenopausal women and OSA prevalence. They concluded 
that OSA prevalence is comparatively higher in postmenopausal than 
premenopausal women [18]. Compared with premenopausal women, 
the postmenopausal group was 3.5 times more likely to have SDB 
defined by an AHI of 15 or more, indicating that menopause was an 
independent risk factor for the development of SDB [19].
Obesity is considered to be one of the major risk factors for OSAS. In 
obese clinical patients, the prevalence of OSAS has been reported to 
be as high as 50%–80% whereas 60%–90% of OSAS patients may 
be overweight [20]. In large epidemiological studies, the association 
between overweight and OSAS in the general population has been 
evaluated, such as Wisconsin Sleep Cohort Study where obesity was 
found to be a significant risk factor for an AHI of ≥5, and a single 
unit increase in BMI was associated with a four-fold increase in OSA 
prevalence [21].
CONCLUSION
From the present study, it can be concluded that the prevalence of OSA 
is considerably high with noticeable variation and increase in age and 
gender. Males are more prevalently affected by OSA in comparison to 
females. However, the statistically significant difference was not found 
in the association of OSA about age and gender.
Graph 2: Prevalence of sleep apnea in different gender. SB: STOP-
Bang Score. Sample size: Male: 507, Female: 505
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